AMBERGEN

AmberGen is a privately held, Boston-area company that enables pioneering discoveries in the life sciences by solving key problems that limit progress in biotechnology and medicine. Our approach combines patented techniques in proteomics, mass spectrometry and light-based control of biomolecules to innovate in the fields of spatial biology, diagnostics and therapeutics... At AmberGen our goal is to create new tools that assist researchers, drug developers, and clinicians, answer the great questions in biology, drug development, and medicine... Next Generation Spatial Biology: AmberGen's patented Miralys™ Photocleavable Mass-Tag Imaging Significantly Boosts the Capability of Mass Spectrometry Imaging

Also known as: Ambergen Inc.